Lifecore Biomedical (LFCR) Tops Q1 EPS by 43c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts LFCR Hot Sheet
Join SI Premium – FREE
Lifecore Biomedical (NASDAQ: LFCR) reported Q1 EPS of $0.43. Revenue for the quarter came in at $23.2 million.
For earnings history and earnings-related data on Lifecore Biomedical (LFCR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oppenheimer raises Microsoft target ahead of earnings amid demand strength
- Northland Upgrades Sono-Tek (SOTK) to Outperform, 'Positioned for Strong FY28'
- Guggenheim Reiterates Neutral Rating on Amgen (AMGN)
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
